Search Results - Kirimis, Evangelia

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract OT1-12-05: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer

    Abstract OT1-12-05: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer by Hurvitz, Sara, Bardia, Aditya, Tetef, Merry L., McAndrew, Nicholas P., Applebaum, Steven, Master, Aashini K., DiNome, Maggie L., Lee, Minna K., Kirimis, Evangelia, Kim, David D., Wang, Lisa S., Greene, Kyle, Phan, Vu, Abdulla, Nihal, Chan, David, Spring, Laura M., Kivork, Christine, Chauv, James

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Abstract GS2-03: GS2-03 TRIO-US B-12 TALENT: Neoadjuvant trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer

    Abstract GS2-03: GS2-03 TRIO-US B-12 TALENT: Neoadjuvant trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer by Bardia, Aditya, Hurvitz, Sara, Press, Michael F., Wang, Lisa S., McAndrew, Nicholas P., Chan, David, Phan, Vu, Villa, Deborah, Tetef, Merry L., Chamberlain, Erin, Abdulla, Nihal, Lomis, Thomas, Spring, Laura M., Applebaum, Steven, Dakhil, Shaker, DiCarlo, Brian, Kim, David D., Kirimis, Evangelia, Lawler, William E., Master, Aashini K., McCann, Kelly, Hayashi, Edwin, Kivork, Christine, Chauv, James

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: